Upcoming Webinars
-
Revolutionizing Medicine: The Race to Unlock the Power of Gene Therapy and Build a Competitive Edge
Gene therapies have been the subject of tremendous research and investment in the biotechnology and pharmaceutical fields.
Register for Revolutionizing Medicine: The Race to Unlock the Power of Gene Therapy and Build a Competitive Edge Read More about Revolutionizing Medicine: The Race to Unlock the Power of Gene Therapy and Build a Competitive Edge
Past Webinars
-
The Future of Cosmetics Regulation is MoCRA - The Modernization of Cosmetics Regulation Act
For the first time since 1938, the U.S. federal cosmetics regulations have been updated with significant implications for businesses in all sectors of the cosmetics industry. MoCRA aligns the cosmetics regulations with other FDA-regulated areas, including food, drugs, and medical devices while also expanding the FDA’s enforcement powers.
Read More about The Future of Cosmetics Regulation is MoCRA - The Modernization of Cosmetics Regulation Act -
Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market
Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market This webinar will cover: • What are the main groups of medical devices impacted? • High level: How to go from EUA to traditional submission (EUA guidance doc). • High level: Phased approach to traditional submission – non-EUA (Phased guidance doc). • Legal ramifications: Overview and Prospective.
Read More about Transition From COVID-19 Emergency: Demystify the FDA Requirements to Keep Your Device on The Market -
Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine
This webinar discusses the Apparent Manufacturer Doctrine under which a nonmanufacturing retailer may be held liable as the manufacturer of a defective product. This doctrine has been ascending in...
Read More about Don’t Think You’re a Manufacturer? You Might Be an Apparent Manufacturer: A Look at the Apparent Manufacturer Doctrine -
Life Sciences Claims 2022: Redefining Normalcy
In this year’s annual year-end wrap-up, a panel including Andy Hall and Lauren Hulbert with Medmarc’s claims department, as well as Jennifer Heis, an attorney with Ulmer Berne, will provide a claims...
Read More about Life Sciences Claims 2022: Redefining Normalcy
Next